Article
iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Biochimica et biophysica acta - 1 May 2016
Deng Xiuling, Wang Jiliang, Jiao Li, Utaipan Tanyarath, Tuma-Kellner Sabine, Schmitz Gerd, Liebisch Gerhard, Stremmel Wolfgang, Chamulitrat Walee
Abstract excerpt
PLA2G6 or GVIA calcium-independent PLA2 (iPLA2β) is identified as one of the NAFLD modifier genes in humans, and thought to be a target for NAFLD therapy. iPLA2β is known to play a house-keeping role in phospholipid metabolism and remodeling. However, its role in NAFLD pathogenesis has not been supported by results obtained from high-fat feeding of iPLA2β-null (PKO) mice. Unlike livers of human NAFLD and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
